Vanguard Information Technology ETF (VGT)
Assets | $80.62B |
Expense Ratio | 0.10% |
PE Ratio | 45.45 |
Shares Out | 133.34M |
Dividend (ttm) | $3.73 |
Dividend Yield | 0.61% |
Ex-Dividend Date | Sep 27, 2024 |
Payout Ratio | 27.93% |
1-Year Return | +34.39% |
Volume | 367,771 |
Open | 612.96 |
Previous Close | 612.17 |
Day's Range | 604.26 - 612.97 |
52-Week Low | 454.77 |
52-Week High | 626.45 |
Beta | 1.17 |
Holdings | 317 |
Inception Date | Jan 26, 2004 |
About VGT
Fund Home PageThe Vanguard Information Technology ETF (VGT) is an exchange-traded fund that mostly invests in information technology equity. The fund tracks a market cap-weighted index of companies in the US information technology sector. VGT was launched on Jan 26, 2004 and is issued by Vanguard.
Top 10 Holdings
58.54% of assetsName | Symbol | Weight |
---|---|---|
Apple Inc. | AAPL | 15.78% |
NVIDIA Corporation | NVDA | 15.41% |
Microsoft Corporation | MSFT | 13.35% |
Broadcom Inc. | AVGO | 4.56% |
Salesforce, Inc. | CRM | 1.84% |
Oracle Corporation | ORCL | 1.81% |
Advanced Micro Devices, Inc. | AMD | 1.52% |
Cisco Systems, Inc. | CSCO | 1.45% |
Adobe Inc. | ADBE | 1.41% |
Accenture plc | ACN | 1.41% |
Dividends
Ex-Dividend | Amount | Pay Date |
---|---|---|
Sep 27, 2024 | $0.9171 | Oct 1, 2024 |
Jun 28, 2024 | $0.7624 | Jul 2, 2024 |
Mar 22, 2024 | $1.259 | Mar 27, 2024 |
Dec 19, 2023 | $0.7946 | Dec 22, 2023 |
Sep 28, 2023 | $0.8814 | Oct 3, 2023 |
Jun 29, 2023 | $0.6757 | Jul 5, 2023 |
News
Vergent Bioscience Completes Enrollment in Phase 2 VISUALIZE Trial Evaluating Potential of Abenacianine for Injection (VGT-309) to Improve Tumor Visualization During Cancer Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced completion of patient enrollment in the company's Phase 2, ...
Breaking Down S&P 500 Returns by Sector Since 2020 Election
The S&P 500 Index has returned nearly 81% since the last presidential election, with a wide disparity between sector performance. The S&P 500's gains since Nov. 3, 2020 reflect an annual return of nea...
VGT: Less Attractive In An Era Of Mega Caps
VGT's concentrated portfolio, with Apple, Nvidia, and Microsoft at 45%, reduces diversification and limits upside potential to 6%. VGT tracks the MSCI US IMI/Information Technology 25/50 Index, which ...
VGT: A Fund For Technology's Next Big Run
VGT is a solid technology sector fund with a low expense ratio and superior risk-adjusted performance, despite slightly lagging its peers in total return. Technology's recent underperformance is due t...
VGT Is A Stronger Investment Option Than QQQ
VGT offers a competitive investment strategy with a lower expense ratio (10bps) and higher yield (0.65%) compared to QQQ, making it a strong buy for tech sector exposure. VGT's portfolio is highly con...
VGT: Relative Strength Suggests Caution Warranted
The Vanguard Information Technology ETF (VGT) is dominated by Apple, NVIDIA, and Microsoft, which together account for 44% of the ETF. The VGT ETF's recent underperformance relative to the S&P 500 sug...
VGT: Insane Concentration Risk
Tech is currently the most overcrowded sector, likely facing a meaningful correction soon, making it a risky allocation right now. Vanguard Information Technology ETF offers broad tech exposure but ha...
VOO, VGT, DIA ETF stocks suffered a harsh reversal: I'm buying
American stocks dived on Friday as concerns that the US was moving into a hard landing continued. The Vanguard S&P 500 ETF (VOO) ETF slumped to $490 on Friday, down by over 5.69% from its highest leve...
VGT: Sector-Specific Concentration And Long-Term Exposure
Exchange-Traded Funds can provide significant portfolio diversification, investing with long-term strategies. VGT is a top-heavy fund with holdings weighted in the Information Technology sector. The f...
VGT: A Higher-Risk Fund That Looks Overvalued Right Now
Vanguard Information Technology ETF has outperformed since 2004, but is heavily concentrated in a few large-cap tech companies. VGT has consistently underperformed the broader NASDAQ index, with core ...
Vergent Bioscience Data Published in The Annals of Thoracic Surgery Demonstrate VGT-309 May Help Surgeons Visualize Tumor Tissue in the Lung During Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that data published in The Annals of Thoracic Surgery reinf...
VGT: Buy This Basket With An Impressive Assortment Of Eggs
The current US economic landscape is unique. Many varying economic forces, making an ideal soft landing a matter of when. VGT has a unique portfolio concentrated enough to reap long-term benefits of t...
VGT: Last Year, IYW Was The Better Choice, But Now, SCHG Offers Safer Tech Exposure
Last Year, I predicted IYW would be a better investment than VGT. IYW has outperformed due to its greater concentration in fewer stocks, and it's tracking an index that includes stocks VGT's index exp...
VGT: Continued Strength As The AI Base Broadens
Vanguard Information Technology ETF offers low fees, and a dividend yield, gaining over 35% since September last year. VGT's outperformance is due to the innovation factor, with companies like Nvidia ...
Tech: Big inflows with one exception
Nathan Geraci, The ETF Store President, joins CNBC's Bob Pisani on ETF Edge to discuss the big inflows into tech.
VGT: This Is The Problem With Buying At Record Valuations
The Vanguard Information Technology ETF has underperformed cash since its 2021 peak, yet its valuation multiple has increased owing to portfolio rebalancing in favor of Nvidia and away from Apple. Ext...
Better Than Venture Capital: Why I Choose VGT Over Its Top Holdings Or QQQ
The VGT ETF focuses on US Information Technology companies and has a low expense ratio compared to similar technology-focused funds. VGT offers wide exposure to US tech companies and is a preferable o...
Accel Entertainment: A VGT Leader Poised For Takeoff
Accel Entertainment is a leader in the VGT market with a loyal customer base and long-term contracts, making it a strong investment opportunity. The company faces competition in the distributed gaming...
VGT: High Growth, High Concentration
Vanguard's Information Technology ETF has had strong historical returns, with a 48.3% return over the past year and an average return of 20% annually over the past 10 years.
Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced new data presented today at the 60th Annual Meeting of The ...
VGT: Nearing Peak Valuation Despite Positive Outlook
Positive outlook for VGT with a forecasted weighted average growth rate of 9.2%, outpacing the overall Tech sector's forecasted CAGR of 6.1%. VGT's higher exposure to rapidly growing sub-industries su...
Vergent Bioscience to Present New Efficacy Results from Phase 2 Clinical Trial of VGT-309 at Annual Meeting of The Society of Thoracic Surgeons
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that new results from the Phase 2 clinical program evaluati...